Molecular Imaging of Precancerous Colorectal Lesions

Abstract Colorectal cancer (CRC) has become the third leading cause of cancer-related deaths in the United States, and the incidence and death rates of the disease in Americans under 50 years-old have risen startlingly in recent years. Critically, however, the 5-year survival rate for CRC is >90% when the disease is detected early, and the malignancy can be avoided completely if lesions are detected while still precancerous. In light of this, the detection of precancerous colorectal lesions  i.e. via colonoscopy  is absolutely crucial to public health. Molecular imaging can be a valuable clinical tool for the visualization of these premalignant tissues, and modalities such as PET, CT, fluorescence, ultrasound, and photoacoustic imaging have been harnessed to detect lesions that may otherwise be difficult to identify during traditional colonoscopies. In this review, we discuss current challenges in the detection of precancerous colorectal lesions, cover the ways in which molecular imaging is currently deployed in this area, and address emergent technologies that have arisen at the intersection of these two fields.

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2026-11-16
DOI
https://doi.org/10.1021/acs.molpharmaceut.6c00896
Primary Topic
Optical Imaging and Spectroscopy Techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular Imaging of Precancerous Colorectal Lesions

Camilla Grimaldi, Brian M. Zeglis, Gina Dehlavi, Erika Patel
Molecular Pharmaceutics
Optical Imaging and Spectroscopy Techniques
article

Molecular Imaging of Precancerous Colorectal Lesions

Camilla Grimaldi, Brian M. Zeglis, Gina Dehlavi, Erika Patel
article en

Abstract

Abstract Colorectal cancer (CRC) has become the third leading cause of cancer-related deaths in the United States, and the incidence and death rates of the disease in Americans under 50 years-old have risen startlingly in recent years. Critically, however, the 5-year survival rate for CRC is >90% when the disease is detected early, and the malignancy can be avoided completely if lesions are detected while still precancerous. In light of this, the detection of precancerous colorectal lesions  i.e. via colonoscopy  is absolutely crucial to public health. Molecular imaging can be a valuable clinical tool for the visualization of these premalignant tissues, and modalities such as PET, CT, fluorescence, ultrasound, and photoacoustic imaging have been harnessed to detect lesions that may otherwise be difficult to identify during traditional colonoscopies. In this review, we discuss current challenges in the detection of precancerous colorectal lesions, cover the ways in which molecular imaging is currently deployed in this area, and address emergent technologies that have arisen at the intersection of these two fields.

Molecular Pharmaceutics
Memorial Sloan Kettering Cancer Center (US), City University of New York (US), Cornell University (US), Weill Cornell Medicine (US)
National Cancer Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being
Optical Imaging and Spectroscopy Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon